Statement of Changes in Beneficial Ownership (4)
September 28 2020 - 07:56PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL
OWNERSHIP OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * ARMISTICE CAPITAL,
LLC |
2. Issuer Name and Ticker or Trading
Symbol Cyclo Therapeutics, Inc. [ CTDH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director __X__
10% Owner
_____ Officer (give title
below) _____ Other
(specify below)
|
(Last)
(First)
(Middle)
510 MADISON AVENUE, 7TH FLOOR, |
3. Date of Earliest Transaction (MM/DD/YYYY)
9/24/2020
|
(Street)
NEW YORK, NY 10022
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line) ___
Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting
Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
|
1.Title of Security
(Instr. 3) |
2. Trans. Date |
2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following
Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock |
9/24/2020 |
|
S |
|
38257 |
D |
$0.13 |
15811235 |
D (1) |
|
Common Stock |
9/24/2020 |
|
S |
|
0 |
D |
$0 |
15811235 |
I |
See Footnote (1) |
Common Stock |
9/28/2020 |
|
S |
|
4966 |
D |
$0.13 |
15806269 |
D (1) |
|
Common Stock |
9/28/2020 |
|
S |
|
0 |
D |
$0 |
15806269 |
I |
See Footnote (1) |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative
Security |
3. Trans. Date |
3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying
Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially
Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of
Responses: |
(1) |
The reported securities (the
"Shares") are directly owned by Armistice Capital Master Fund Ltd.,
a Cayman Islands exempted company (the "Master Fund"), and may be
deemed to be indirectly beneficially owned by: (i) Armistice
Capital, LLC ("Armistice Capital"), as the investment manager of
the Master Fund; and (ii) Steven Boyd, as the Managing Member of
Armistice Capital. Armistice Capital and Steven Boyd disclaim
beneficial ownership of the reported securities except to the
extent of their respective pecuniary interests therein, and this
report shall not be deemed an admission that either of them are the
beneficial owners of the securities for purposes of Section 16 of
the Securities Exchange Act of 1934, as amended, or for any other
purpose. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
ARMISTICE CAPITAL, LLC
510 MADISON AVENUE, 7TH FLOOR
NEW YORK, NY 10022 |
|
X |
|
|
Armistice Capital Master Fund Ltd.
C/O DMS CORPORATE SERVICES LTD.
20 GENESIS CLOSE, P.O. BOX 314
GRAND CAYMAN, E9 KY1-1104 |
|
X |
|
|
Boyd Steven
C/O ARMISTICE CAPITAL, LLC
510 MADISON AVENUE, 7TH FLOOR
NEW YORK, NY 10022 |
|
X |
|
|
Signatures
|
Armistice Capital, LLC By: /s/ Steven Boyd,
Managing Member |
|
9/28/2020 |
**Signature of
Reporting Person |
Date |
Armistice Capital Master Fund Ltd.By: /s/ Steven
Boyd, Director |
|
9/28/2020 |
**Signature of
Reporting Person |
Date |
/s/ Steven Boyd |
|
9/28/2020 |
**Signature of
Reporting Person |
Date |
Cyclo Therapeutics (QB) (USOTC:CTDH)
Historical Stock Chart
From Dec 2020 to Jan 2021
Cyclo Therapeutics (QB) (USOTC:CTDH)
Historical Stock Chart
From Jan 2020 to Jan 2021